Sökning: onr:"swepub:oai:DiVA.org:liu-102497" >
Allogeneic stem cel...
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
-
- Thiel, U (författare)
- Technical University of Munich, Germany
-
- Koscielniak, E (författare)
- Klinikum Stuttgart, Germany
-
- Blaeschke, F (författare)
- Technical University of Munich, Germany
-
visa fler...
-
- Grunewald, T G P. (författare)
- Technical University of Munich, Germany
-
- Badoglio, M (författare)
- Hop St Antoine, France
-
- Diaz, M A. (författare)
- Hospital Infantil University of Nino Jesus, Spain
-
- Paillard, C (författare)
- CHU Clermont Ferrand, France
-
- Prete, A (författare)
- Osped S Orsola Malpighi, Italy
-
- Ussowicz, M (författare)
- Wroclaw Medical University, Poland
-
- Lang, P (författare)
- University of Childrens Hospital, Germany
-
- Fagioli, F (författare)
- Regina Margherita Childrens Hospital, Italy
-
- Lutz, P (författare)
- Hop Hautepierre, France
-
- Ehninger, G (författare)
- University Hospital Carl Gustav Carus, Germany
-
- Schneider, P (författare)
- Rouen University Hospital, France
-
- Santucci, A (författare)
- University of Perugia, Italy
-
- Bader, P (författare)
- Goethe University of Frankfurt, Germany
-
- Gruhn, B (författare)
- Jena University Hospital, Germany
-
- Faraci, M (författare)
- G Gaslini Childrens Research Institute, Italy
-
- Antunovic, Petar (författare)
- Linköpings universitet,Institutionen för klinisk och experimentell medicin,Hälsouniversitetet
-
- Styczynski, J (författare)
- Coll Medical UMK, Poland
-
- Krueger, W H. (författare)
- Ernst Moritz Arndt University of Greifswald, Germany
-
- Castagna, L (författare)
- Ist Clin Humanitas, Italy
-
- Rohrlich, P (författare)
- University of Franche Comte, France
-
- Ouachee-Chardin, M (författare)
- Hop Robert Debre, France
-
- Salmon, A (författare)
- CHU Nancy Brabois, France
-
- Peters, C (författare)
- St Anna Childrens Hospital, Austria
-
- Bregni, M (författare)
- Osped Circolo, Italy
-
- Burdach, S (författare)
- Technical University of Munich, Germany
-
visa färre...
-
(creator_code:org_t)
- 2013-10-22
- 2013
- Engelska.
-
Ingår i: British Journal of Cancer. - : Cancer Research UK. - 0007-0920 .- 1532-1827. ; 109:10, s. 2523-2532
- Relaterad länk:
-
https://www.nature.c...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Allogeneic haematopoietic stem cell transplantation (allo-SCT) may provide donor cytotoxic T cell-/NK cell-mediated disease control in patients with rhabdomyosarcoma (RMS). However, little is known about the prevalence of graft-vs-RMS effects and only a few case experiences have been reported. less thanbrgreater than less thanbrgreater thanMethods: We evaluated allo-SCT outcomes of 30 European Group for Blood and Marrow Transplantation (EBMT)-registered patients with advanced RMS regarding toxicity, progression-free survival (PFS) and overall survival (OS) after allo-SCT. Twenty patients were conditioned with reduced intensity and ten with high-dose chemotherapy. Twenty-three patients were transplanted with HLA-matched and seven with HLA-mismatched grafts. Three patients additionally received donor lymphocyte infusions (DLIs). Median follow-up was 9 months. less thanbrgreater than less thanbrgreater thanResults: Three-year OS was 20% (s. e.+/- 8%) with a median survival time of 12 months. Cumulative risk of progression was 67% (s. e.+/- 10%) and 11% (s. e.+/- 6%) for death of complications. Thirteen patients developed acute graft-vs-host disease (GvHD) and five developed chronic GvHD. Eighteen patients died of disease and four of complications. Eight patients survived in complete remission (CR) (median: 44 months). No patients with residual disease before allo-SCT were converted to CR. less thanbrgreater than less thanbrgreater thanConclusion: The use of allo-SCT in patients with advanced RMS is currently experimental. In a subset of patients, it may constitute a valuable approach for consolidating CR, but this needs to be validated in prospective trials.
Nyckelord
- rhabdomyosarcoma
- allogeneic haematopoietic stem cell transplantation
- graft-vs-tumour effect
- reduced intensity conditioning
- myeloablative conditioning
- donor lymphocyte infusion
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Thiel, U
-
Koscielniak, E
-
Blaeschke, F
-
Grunewald, T G P ...
-
Badoglio, M
-
Diaz, M A.
-
visa fler...
-
Paillard, C
-
Prete, A
-
Ussowicz, M
-
Lang, P
-
Fagioli, F
-
Lutz, P
-
Ehninger, G
-
Schneider, P
-
Santucci, A
-
Bader, P
-
Gruhn, B
-
Faraci, M
-
Antunovic, Petar
-
Styczynski, J
-
Krueger, W H.
-
Castagna, L
-
Rohrlich, P
-
Ouachee-Chardin, ...
-
Salmon, A
-
Peters, C
-
Bregni, M
-
Burdach, S
-
visa färre...
- Artiklar i publikationen
-
British Journal ...
- Av lärosätet
-
Linköpings universitet